A. Strnad

Erratum to: Primary glioblastoma multiforme tumors and recurrence: comparative analysis of the danger signals HMGB1, HSP70, and calreticulin

R. Fietkau, R. Buslei, B. Frey, 2016, Strahlentherapie und Onkologie.

Primary glioblastoma multiforme tumors and recurrence

R. Fietkau, R. Buslei, B. Frey, 2015, Strahlentherapie und Onkologie.

Modulations in the Peripheral Immune System of Glioblastoma Patient Is Connected to Therapy and Tumor Progression—A Case Report from the IMMO-GLIO-01 Trial

R. Fietkau, N. Goerig, B. Frey, 2017, Front. Neurol..

Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines

R. Fietkau, R. Buslei, A. Derer, 2014, Radiation oncology.

Evidence for improved survival with bevacizumab treatment in recurrent high-grade gliomas: a retrospective study with (“pseudo-randomized”) treatment allocation by the health insurance provider

R. Fietkau, I. Eyüpoglu, F. Putz, 2020, Journal of Neuro-Oncology.

Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.

R. Fietkau, V. Strnad, M. Lotter, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.